🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Related News

Cambrian Bioworks raises $1.45 Mn in seed round

EntrackrEntrackr · 1y ago
Cambrian Bioworks raises $1.45 Mn in seed round
Medial

Bengaluru-based biotechnology firm Cambrian Bioworks has secured $1.45 million in its seed round led by the Irani family office, which has invested in several private ventures across the globe. The round also saw participation from the company’s CEO and co-founder, Vaibhav Hegde. The proceeds will be used to ramp up development of Cambrian’s automated molecular diagnostics platforms, R&D efforts, expand the team, and support forays into international markets. Founded by Hegde, Rohit Asil, and Raghav Sridhar, Cambrian Bioworks develops automated molecular diagnostic platforms. Its products find applications in oncology, genomics, rare disease testing, and AMR detection. Recently, the firm launched Cambrian’s nucleic acid extraction platform, Manta which provides high-quality DNA/RNA for genomics and PCR testing in hospitals and laboratories. This is yet another example of a founder investing in his own startup. This trend started with the founders of Byju’s, OYO, and BluSmart, and has recently continued with investments from the founders of Yubi and Ather Energy.

CrisprBits raises $3 Mn led by Spectrum Impact

EntrackrEntrackr · 1m ago
CrisprBits raises $3 Mn led by Spectrum Impact
Medial

CrisprBits raises $3 Mn led by Spectrum Impact CrisprBits will deploy the new funds to scale commercialisation of its PathCrisp molecular diagnostics platform and expand manufacturing for tests in human health, food safety and animal health. Bengaluru-based biotechnology startup CrisprBits has raised $3 million from founders, angels and family offices, taking its valuation to $12 million. The Pre-Series A round was led by Spectrum Impact, the family office of Rajendra Gogri, Chairman and Managing Director of Aarti Industries. Existing backers including Vijay Alreja Family Office (VJ Technologies Group) also participated, along with new investors from the promoter family of HBL Engineering. The company had earlier raised capital from founders, VJ Technologies Group and C-CAMP. CrisprBits will deploy the new funds to scale commercialisation of its PathCrisp molecular diagnostics platform and expand manufacturing for tests in human health, food safety and animal health. The company is also developing a CRISPR-driven strain engineering platform, starting with biofuel production processes. Founded by Vijay Chandru, Sunil Arora, Rajeev Kohli, Bharat Jobanputra and Aditya Sarda, CrisprBits operates a 7300 sq ft CRISPR R&D and prototype development facility in Bengaluru. The company runs three platforms: PathCrisp for molecular diagnostics, EdiCrisp for gene editing and strain engineering, and CurieCrisp for preclinical and rare disease-focused therapeutics. Over the next six months, CrisprBits plans to expand its CRISPR diagnostic products to global markets including Africa and Latin America. It will further strengthen operations by scaling infrastructure and production capabilities at its diagnostics manufacturing facility. The firm also aims to build an AI-augmented strain engineering platform for sustainability applications.

LEAP India, Molbio Diagnostics secure SEBI nod for IPO

EntrackrEntrackr · 15d ago
LEAP India, Molbio Diagnostics secure SEBI nod for IPO
Medial

LEAP India, Molbio Diagnostics secure SEBI nod for IPO Logistics solutions firm LEAP India and Goa-based molecular diagnostics company Molbio Diagnostics have secured approval from the Securities and Exchange Board of India (SEBI) to launch their initial public offering (IPO). The regulator’s observations, published recently, mark a significant milestone for both companies as they prepare to enter the public markets. The approvals come months after LEAP India filed its draft red herring prospectus (DRHP) to raise up to Rs 2,400 crore. The issue comprises a fresh issue of Rs 400 crore and an offer for sale (OFS) of Rs 2,000 crore. The OFS will be led primarily by Vertical Holdings II Pte. Ltd., a promoter entity backed by global investment firm KKR, which plans to divest shares worth Rs 1,998.6 crore. Another promoter group entity, KIA EBT Scheme 3, will offload shares worth around Rs 13.8 crore. Ahead of its plans to go public, the company converted itself into a public limited entity in July 2025 and appointed independent directors to strengthen its board, a development earlier reported exclusively by Entrackr. LEAP India, which provides pallet, container, and asset-pooling solutions to large FMCG, e-commerce, and pharma companies, has been expanding its fulfilment centres and customer touchpoints to tap the surge in demand for organised supply-chain infrastructure. In FY25, the firm reported 28% YoY revenue growth to Rs 466 crore, while maintaining its Rs 37.5 crore PAT, on the back of higher asset utilisation. Meanwhile, in August 2025, Molbio Diagnostics filed its DRHP proposing a fresh issue of Rs 200 crore and an OFS of up to 1.25 crore shares. Selling shareholders include Exxora Trading LLP, Dr Chandrasekhar Bhaskaran Nair, Abdul Qadir Mohamed Theruvath, among others. Molbio, known for its Truenat point-of-care molecular testing platform deployed across TB, HPV, COVID-19, and other infectious diseases, plans to use the IPO proceeds to expand manufacturing capacity and boost R&D infrastructure. The company logged Rs 1,020 crore in revenue and Rs 138.5 crore profit in FY25, reaffirming the growing demand for decentralised diagnostics solutions in India and emerging markets.

Climate tech startup Resilience AI bags $1 Mn in seed round

EntrackrEntrackr · 1y ago
Climate tech startup Resilience AI bags $1 Mn in seed round
Medial

Resilience AI, a climate risk and sustainability technology firm, has raised $1 million in its seed funding round led by Kalaari Capital's CXXO initiative, which invests in ventures led by women entrepreneurs. The round also saw participation from Java Capital. The proceeds will be used to drive the development of Resilience360, offering end-to-end climate risk management solutions for private and public enterprises. Additionally, the startup aims to co-develop solutions with its customers, expand market access, and drive research-based innovation. Founded by Samhita R, Resilience360 addresses the need for a proactive approach to climate resilience, enabling organizations to prepare for extreme climate events such as heatwaves, floods, cyclones, landslides, and earthquakes. By combining machine learning and deep climate analytics, the platform provides hyperlocal risk maps, automated climate risk diagnostics, and institutionalized climate action plans that integrate sustainability and climate risk standards. The platform's flagship product Resilience360 offers hyperlocal climate risk baseline and mapping; Plan, enabling the development of tailored risk controls; Action, focused on the implementation and reporting of climate measures; and Scale, which supports ongoing monitoring and the expansion of adaptation strategies.

Download the medial app to read full posts, comements and news.